Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma

Clinical trial NCT07648069 · RECRUITING

Trial details

NCT number: NCT07648069
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Soft Tissue Sarcoma (STS)Osteosarcoma

Start date: 2024-09-03
Primary completion: 2026-12-31
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.